Algo version: 0.98b
Clínica Baviera, S.A. is listed at the EURONEXT Exchange
Clínica Baviera, S.A. [CBAV.MC]
EURONEXT Sector: Healthcare Industry:Diagnostics & Research

Is Clínica Baviera, S.A. stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Clínica Baviera, S.A. pays dividends. Last time was Thursday 18th of July 2024 where the investors holding the stock on Tuesday 16th of July 2024 were paid €1.57 per share. Over the last 22 times between 2008 and 2024, Clínica Baviera, S.A. has paid €8.142 with an average of €0.37 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Clínica Baviera, S.A. 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was €14.25, you would have made a profit of €16.75 per share or 117.54%

No, the average daily trading liquidity for Clínica Baviera, S.A. is €3 493 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Clínica Baviera, S.A. has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 1.32, the company's ability to pay off the debt is good. Clínica Baviera, S.A. has a good net profit margin of 15.86% and should have high tolerances against inflation.

We have calculated the inflation risk for Clínica Baviera, S.A. to be low [0.25 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.